NEW JERSEY ALLIANCE FOR
CLINICAL AND TRANSLATIONAL SCIENCE


NEWS, EVENTS, and DEADLINES
December 15, 2021
Season's Greetings from NJ ACTS
A Message from Reynold A. Panettieri, Jr, MD
NJ ACTS Program Director
Dear Members of the NJ ACTS Community:
As the end of the year approaches, I want to wish the entire NJ ACTS community a joyous holiday season and the very best for 2022.
We are in the process of reviewing NJ ACTS activities and progress in 2021 for our annual report to NIH. It's amazing how much was done to strengthen our community by providing new programs, infrastructure and services. To those who contributed in any way to these development, my heartiest thanks and congratulations. You have much to be proud of.
To those who joined our program as KL2 career scientists, pilot awardees, TL trainees, community advisors, learners, or service requestors, we thank you for your active participation in NJ ACTS and in clinical and translational research and science. We are here to meet you needs and we welcome your suggestions for even more responsive and effective programming in 2022. 
Thank you,
Rey
Upcoming NJ ACTS and Rutgers Events

NJ ACTS Regulatory Consult Cafés
Beginning in January!


Do you need help regarding any facet of human subjects protection, FDA requirements or other regulatory issues?

Join the Regulatory Knowledge and Support Core Staff at its cafés.



MONDAYS
The second Monday of every month

Starting January 10, 2022
10 -11 am

Meeting ID: 925 1379 9432
Password: 752512


THURSDAYS
The last Thursday of every month

Starting January 27, 2022
2 - 3 pm

Meeting ID: 964 4107 5926
Password: 043311


Questions? Contact Anthony Gonzalez


...and More Events of Interest

New Format Workshop
for NIH Biosketches and Other Support

The new NIH Biosketch and Other Support Forms are required for all application due dates and RPPR submissions on/after January 25, 2022. This workshop will guide participants on creating the NIH Biosketch and Other Support in the new formats. 
 
December 20, 2021
12 – 1pm 
 
Audience: Rutgers researchers, research administrators, and/or any Rutgers user who is interested to learn about the new format. 
 
Instructor: Yingting Zhang, MLS, AHIP

Research Resources Workshop
Wednesday Series

University-Industry Partnerships
Sacha Patera, PhD
Associate Vice President, RU Corporate Engagement Center
Najoua Borkadi, PhD
Executive Director of Research Business Development, RBHS

January 12, 2022
4 - 5 pm
DEADLINES

NJ ACTS Community Engagement Core
Offers Seed Grants

2022 PIAP Grant Program Application Due

The Partnership and Innovation Accelerator Pilot Program (PIAP) is calling for applications for the 2022 cycle. PIAP grants are one-year competitive awards between community organizations and academic researchers from Rutgers, Princeton, and/or New Jersey Institute of Technology working together on health research that benefits our communities. 


Application Deadline: January 1, 2022
NJ ACTS Publications


Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study. Horton, Daniel B.; Barrett, Emily S.; Roy, Jason; Gennaro, Maria Laura; Andrews, Tracy; et al. Journal Of Infectious Diseases. 2021 Oct 28;224(8):1345-1356.
In Case You Missed IT
On the Pandemic Podcast - Episode 3: What to Expect this Holiday Season
Listen on : APPLE, SPOTIFY, GOOGLE, ANCHOR, RADIO PUBLIC
ERRATA

In our November 23rd issue, we incorrectly stated that NJMS Inventors Received the 2021 Edison Patent Award in Biotechnology, however they were RWJMS Inventors.
 
Therefore, NJ ACTS would like to congratulate Robert Wood Johnson Medical School faculty members, Michael G. Dunn, PhD, Charles J. Gatt, Jr., MD, and Eric A. Balint, PhD, on receiving the 2021 Thomas Edison Patent Award in Biotechnology for their invention, “Bioresorbable Tissue Engineered Fibrocartilage Replacement with Three-Dimensional Matrix of Fibers.”
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
Components